Fundraising Fox

SynerGene Therapeutics

Potomac, US

Founders & leadership

MM
Maria Malena RuizExecutive

Board

JH
James HsuBoard director
SC
Samuel ChangBoard director

Reported raises · per SEC filings

Form D private placements

$9.6M disclosed across 3 rounds · 2014

$6.4MraisedDec 2014 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Maria Magdalena RuizExecutive Officer
  • James HsuDirector
  • Samuel ChangDirector
Offering amount
$7.2M
Amount sold
$6.4M
Minimum investment
$33K
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$860KraisedJun 2014 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James HsuDirector
  • Samuel ChangDirector
  • Maria Magdalena RuizExecutive Officer
Offering amount
$1M
Amount sold
$860K
Minimum investment
$20K
First sale
Jun 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.4MraisedApr 2014 · 38 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James HsuDirector
  • Samuel ChangDirector
  • Maria Malena RuizExecutive Officer
Offering amount
$3M
Amount sold
$2.4M
Minimum investment
$10K
First sale
Mar 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has SynerGene Therapeutics raised?
SynerGene Therapeutics has disclosed $9.6M raised across 3 rounds.
Where is SynerGene Therapeutics headquartered?
SynerGene Therapeutics is headquartered in Potomac, US.